Physician profile
Jonathan Quin Bailey
NPI 1487697504
$1,403.99
in general payments reported to CMS, 2019-2025
14 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $87.20 · 2022: $21.38 · 2023: $373 · 2024: $380 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705 · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.20 |
| Education | $382.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $587.05 | 2023-2025 | Veozah |
| Minerva Surgical, INC | $173.84 | 2019 | |
| Trisalus Life Sciences, INC. | $139.77 | 2025 | Trinav Infusion System |
| Coopersurgical, INC. | $132.89 | 2023-2025 | Summit Doppler, Sos |
| Mayne Pharma Commercial LLC | $69.61 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.72 | 2025 | |
| Organon LLC | $63.92 | 2024-2025 | Nexplanon |
| Davol INC. | $54.09 | 2020 | |
| Millicent US INC | $32.63 | 2019-2020 | |
| Sage Therapeutics, LLC | $23.05 | 2024 | |
| Covidien LP | $18.08 | 2019 | |
| Therapeuticsmd, INC. | $15.79 | 2020 | |
| Innovation Technologies INC | $14.83 | 2025 | Irrisept |
| Medtronic, INC. | $13.72 | 2023 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.